GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rockwell Medical Inc (NAS:RMTI) » Definitions » Shiller PE Ratio

Rockwell Medical (Rockwell Medical) Shiller PE Ratio : (As of Jun. 06, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Rockwell Medical Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Rockwell Medical Shiller PE Ratio Historical Data

The historical data trend for Rockwell Medical's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rockwell Medical Shiller PE Ratio Chart

Rockwell Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Rockwell Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Rockwell Medical's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rockwell Medical's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Shiller PE Ratio falls into.



Rockwell Medical Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Rockwell Medical's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Rockwell Medical's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.06/131.7762*131.7762
=-0.060

Current CPI (Mar. 2024) = 131.7762.

Rockwell Medical Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.880 100.560 -1.153
201409 -1.100 100.428 -1.443
201412 -1.650 99.070 -2.195
201503 -0.770 99.621 -1.019
201506 -0.550 100.684 -0.720
201509 -0.550 100.392 -0.722
201512 -1.320 99.792 -1.743
201603 -1.100 100.470 -1.443
201606 -1.210 101.688 -1.568
201609 -0.990 101.861 -1.281
201612 -1.100 101.863 -1.423
201703 -0.990 102.862 -1.268
201706 -1.540 103.349 -1.964
201709 -1.100 104.136 -1.392
201712 -1.980 104.011 -2.509
201803 -1.210 105.290 -1.514
201806 -2.640 106.317 -3.272
201809 -1.100 106.507 -1.361
201812 -1.870 105.998 -2.325
201903 -1.650 107.251 -2.027
201906 -1.980 108.070 -2.414
201909 -1.320 108.329 -1.606
201912 -1.210 108.420 -1.471
202003 -1.320 108.902 -1.597
202006 -1.100 108.767 -1.333
202009 -1.100 109.815 -1.320
202012 -0.990 109.897 -1.187
202103 -0.910 111.754 -1.073
202106 -0.990 114.631 -1.138
202109 -0.890 115.734 -1.013
202112 -1.040 117.630 -1.165
202203 -0.840 121.301 -0.913
202206 -0.430 125.017 -0.453
202209 -0.230 125.227 -0.242
202212 -0.200 125.222 -0.210
202303 -0.100 127.348 -0.103
202306 -0.180 128.729 -0.184
202309 -0.070 129.860 -0.071
202312 -0.050 129.419 -0.051
202403 -0.060 131.776 -0.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Rockwell Medical  (NAS:RMTI) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Rockwell Medical Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Rockwell Medical's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rockwell Medical (Rockwell Medical) Business Description

Traded in Other Exchanges
Address
30142 S. Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. Rockwell Medical's mission is to provide dialysis clinics and patients with the highest quality products supported by the best customer service in the industry. It is focused on innovative, long-term growth strategies that enhance products, processes, and people, enabling the company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.
Executives
Jesse Neri officer: SVP, FINANCE 851 DUPORTAIL ROAD, SECOND FLOOR, CHESTERBROOK PA 19087
Joan Lau director C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Russell Skibsted officer: See Remarks 15 TRANQUILITY PLACE, LADERA RANCH CA 92694
Megan C. Timmins officer: SVP, General Counsel 600 LEE ROAD, SUITE 100, WAYNE PA 19087
Mark Strobeck director, officer: President and CEO 460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087
Allen Nissenson director 601 HAWAII ST., EL SEGUNDO CA 90245
Robert S Radie director 101 LINDENWOOD DRIVE, SUITE 225, MALVERN PA 19355
Andrea Heslin Smiley director 600 LEE ROAD, SUITE 100, WAYNE PA 19087
David S. Richmond 10 percent owner, other: See Footnote 1 3568 WILDWOOD AVENUE, JACKSON MI 49202
Russell H Ellison director 270 RIVERSIDE DR., APT. 12D, NEW YORK NY 10025
Marc L Hoffman officer: Chief Medical Officer 30142 WIXOM ROAD, WIXOM MI 48393
John Peter Mclaughlin director C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BOULEVARD, INCLINE VILLAGE NV 89451
Richmond Brothers, Inc. 10 percent owner, other: See Footnote 1 7415 FOXWORTH COURT, JACKSON MI 49201
Stuart M Paul director, officer: Chief Executive Officer HOME DIAGNOSTICS, INC., 2400 NW 55TH COURT, FORT LAUDERDALE FL 33309
Angus W. Smith officer: Chief Financial Officer C/O PERNIX THERAPEUTICS HOLDINGS, INC., 10 NORTH PARK PLACE, SUITE 201, MORRISTOWN NJ 07960